Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy

NCT03135977 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer
Lung Cancer

Interventions

DRUG: Apatinib, Etoposide

Sponsor

Sichuan Cancer Hospital and Research Institute